Depomed Inc. (DEPO) announced that it has filed a lawsuit against Lupin Ltd. and its subsidiary, Lupin Pharma Inc., for infringement of the patents listed in the Orange Book for GLUMETZA.
The company said the lawsuit is in response to an Abbreviated New Drug Application filed by Lupin with the U.S. FDA regarding Lupin's intent to market generic versions of 500mg and 1000mg strengths of GLUMETZA prior to the expiration of the four listed patents.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.